The Trump administration promised to drastically cut prescription drugs prices in the US, where the industry makes most of its money.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Both Target and TJ Maxx posted stellar earnings results on the strength of the incredibly resilient US consumer.
Antitrust regulators in India flagged Disney’s $8.5 billion merger with Reliance for competition concerns in cricket broadcast rights.
The European Commission on Tuesday solidified new tariffs for electric vehicles imported from China. The actual numbers aren’t harsh.
The UK and US announced a “historic” trade deal Thursday that does little to reduce Washington’s overall global trade war.
Functional beverages — drinks producers tout as having health benefits because they have been infused with bioactive compounds.
After nearly 3,000 years, the business of the Olympics is ripe for disruption. Could performance enhancing drugs shake up the games?
The World Health Organization has declared mpox to be a public health emergency, and pharmaceutical and healthcare winners have emerged.
De Beers, the world’s largest diamond producer, said it plans to shutter its lab-grown jewelry brand LightBox.
Mars announced on Wednesday that it has agreed to buy snack maker Kellanova, a spin-off from Kellogg’s, for a mouth-watering $35.9 billion.
For Starbucks chief Laxman Narasimhan, the daily grind is over. The embattled coffee chain named Chipotle CEO Brian Niccol his successor.
As Paramount moves under the control of Skydance Media, current leadership is undergoing a campaign to realize half a billion in savings.
Netflix is rolling out the first major redesign of its home hub since 2013, hoping people might watch more if inundated with less.
Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.